Doxycycline Hyclate Tablet, Delayed Release
Brand names: Doxycycline Hyclate
Category: Anti-Infective
FDA status: To Be Discontinued · Last FDA update: Jul 30, 2026 · First posted: Jul 30, 2026 · 1 manufacturers, 2 listed presentations
As of Jul 30, 2026, the FDA lists Doxycycline Hyclate Tablet, Delayed Release as being discontinued. Of 2 manufacturer presentations, 2 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Doxycycline Hyclate, Tablet, Delayed Release, 50 mg (NDC 0591-4550-22) NDC 0591-4550-22 |
Teva Pharmaceuticals USA, Inc. | Not specified | Discontinuation of the manufacture of the drug |
| Doxycycline Hyclate, Tablet, Delayed Release, 200 mg (NDC 0591-4575-60) NDC 0591-4575-60 |
Teva Pharmaceuticals USA, Inc. | Not specified | Discontinuation of the manufacture of the drug |
Related medications in shortage
Other Anti-Infective medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Doxycycline Hyclate Tablet, Delayed Release (FDA data as of Jul 30, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Doxycycline Hyclate Tablet, Delayed Release. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/doxycycline-hyclate-tablet-delayed-release.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).